Biosimilars, Generic Drugs, and the Pharmaceutical Industry

biosimilars

Author: Chad Eichman, PhD – BioPharmaceutical Global Marketing Manager How Biosimilars are Affecting the Pharmaceutical Industry Honey Nut Cheerios™ or Honey Nut Tasteeos®? Glad® Trash Bags or Walmart’s Great Value™ Continue Reading

Have a Technical Question? Live Chat with Experts!

live chat

Scientists are some of the smartest people to walk the planet. But even basic chromatography knowledge can evade the most experienced scientist. That is why Phenomenex provides technical assistance nearly Continue Reading

Biopharmaceutical and Biologics Glossary of Key Terms

biologics glossary

When working in biopharmaceutical or biologics analysis, you need as many tools as possible. Be it that you’re looking for the right instruments (like our new bioZen™ LC columns), the Continue Reading

What is Drug Antibody Ratio and How Does It Relate to Biotherapeutics?

DAR: Drug Antibody Ratio

Meet James Song, R&D Research Scientist– Bioseparations James has over 20 years of experience in the arena of biotechnology and has a wealth of experience in the fields of diagnostic Continue Reading

Large vs Small Organic Molecules in Biopharmaceuticals

Biopharmaceuticals

Biopharmaceuticals have emerged as the next-gen of therapeutic (large and small) molecules in the pharmaceutical industry Guest Author: Chad Eichman, Ph.D., Biopharmaceutical Industry Manager The pharmaceutical industry has a long-standing Continue Reading

Doing HPLC Method Development for Monoclonal Antibody Aggregates? Wait a “SEC”!

By Guest Author: Brian Rivera Contrary to popular belief, size exclusion chromatography (SEC) isn’t straightforward. However, it should be—it’s a non-absorptive separation, right? Just look up an SEC column’s calibration Continue Reading